Select Page

Pharmacy Latest Research Output: 2020

  1. Home
    2.  » 
  2. Latest Research Output
    3.  » Pharmacy Latest Research Output: 2020

ACCREDITED JOURNALS

  • Engler D; Meyer JC; Schellack N; Kurdi A and Godman B. Compliance with South Africa’s antimicrobial resistance national strategy framework: are we there yet? Journal of Chemotherapy 2020; 2020: 1-11
  • Twilley D; Moodley D; Rolfes H; Moodley I; McGaw LJ; Madikizela B; Summers B; Raaff L-A; Lategan M; Kgatuke L; Mabena EC and Lall N. Ethanolic extracts of South African plants, buddleja saligna willd. And helichrysum odoratissimum (l.) sweet, as multifunctional ingredients in sunscreen formulations. South African Journal of Botany 2020; 137: 1-12
  • Adeleke OA; Hayeshi RK and Davids H. Development and evaluation of a reconstitutable dry suspension containing isoniazid for flexible pediatric dosing. Pharmaceutics 2020; 12 (286): 194-208
  • Matawo N; Adeleke OA and Wesley-Smith J. Optimal design, characteristics and preliminary safety evaluation of an edible orodispersible formulation for pediatric tuberculosis pharmacotherapy. International Journal of Molecular Sciences 2020; 21 (5714): 1-27
  • Okide CC; Grey-Ekejiuba O; Ubaka CM; Schellack N and Okanta M. Parents’ knowledge, attitudes and use of antibiotics in upper respiratory infections in Nigerian children. African Journal Biomedical Research 2020; 23 (2): 213-220
  • Schellack N; Coetzee M; Schellack G; Gijzelaar M; Hassim Z; Milne M; Bronkhorst E; Padayachee N; Singh N; Kolman S and Gray AL. COVID-19: Guidelines for pharmacists in South Africa. Southern African Journal of Infectious Diseases 2020; 35(1): 1-10
  • Schellack N; Schellack G and Esterhuizen A. Shifting the paradigm in the management of conditions affecting the thyroid gland. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2020; 25(10): 28-34
  • Schellack N; Mogole O; Magongwa N and Makola F. Migraine headaches: a brief overview. SA Pharmaceutical Journal 2019; 86(1): 28-32
  • Schellack N; du Toit J; Mokoena T and Bronkhorst E. Fungal infections-an overview. SA Pharmaceutical Journal 2019; 86(1): 33-40
  • Wadesango L; Nxumalo N and Schellack N. An overview of throat lozenges and sprays in the management of phyryngitis at primary care level. SA Pharmaceutical Journal 2019; 86(2): 17-20
  • Mokwele RN; Ndzamba BS and Schellack N. Bacterial vaginosis: an overview. SA Pharmaceutical Journal 2019; 86(2): 13-16
  • Schellack N; Shirindza N and Mokoena T. An overview of allergic conjunctivitis. SA Pharmaceutical Journal 2019; 86(4): 13-22
  • Padayachee N; Lundie M, Schellack N; Dlamini Z and Esterhuizen A. Taking the pain out of back pain with effective lower back pain management-an overview. SA Pharmaceutical Journal 2019; 86(4): 29-37
  • Schellack N; Thom L; du Toit J; Grobbelaar S; Mokoena T and Kadiwa RT. Changes in terminology and management of over-the-counter cough therapy-time for a fresh perspective? SA Pharmaceutical Journal 2019; 86(3): 35-42
  • Schellack N; Mogale K; Wadesango L and Nxumalo N. Bisphosphonate medicine use in the management of osteoporosis. SA Pharmaceutical Journal 2019; 86(3): 30-34
  • Dlamini Z; Kupa K and Schellack N. Colds and flu-an overview of their management. SA Pharmaceutical Journal 2019; 86(3): 16-22
  • Schellack G; Harirari P and Schellack N. Vitamin B-complex deficiency, supplementation and management. SA Pharmaceutical Journal 2019; 86(3): 23-29
  • Bronkhorst E; Adries GS and Schellacl N. Practice guidelines for clinical pharmacists in middle to low income countries. Frontiers in Pharmacology 2020; 11(978): 1-10
  • Schellacl N; du Toit J; Mokoena Tand Bronkhorst E. Mycoses and anti-fungals-an update. SA Pharmaceutical Journal 2020; 87(1): 18-25
  • Hollander C; Joubert K and Schellacl N. An ototoxicity grading system within a mobile app (otocalc) for a resource-limited setting to guide grading and management of drug-induced hearing loss in patients with drug-resistant tuberculosis: prospective, cross-sectional case series. JMIR mHealth and uHealth 2020; 8(1)
  • Schellack N; Schellack G and Ismail H. An overview of cold and flu management. SA Pharmaceutical Journal 2020; 87(3): 38-42
  • Schellack G and Schellack N. Adult patients with cardiac failure: an update. SA Pharmaceutical Journal 2020; 87(2): 13-21
  • Schellack G; Schellack N and Bronkhorst E. Smoking cessation in review. SA Pharmaceutical Journal 2020; 87(3): 43-46
  • Pierce J; Apisarnthanarak A; Schellack N; Cornistein W; Al Maani A; Adnan S and Stevens MP. Global antimicrobial stewardship with a focus on low-and middle-income countries; a position statement for the international society for infectious diseases. International Journal of Infectious Diseases 2020; 96: 621-629
  • Dias CZ; Godman B; Gargano LP; Azevedo PS; Garcia MM; Cazarim MS; Pantuzza LLS; Ribeiro-Junior NG; Pereira AL; Borin MC; de Figueiredo Zuppo; Lunes R; Pippo T; Hauegen RC; Vassalo C; Laba TL; Simoens S; Marquez S; Gomez C; Voncina L; Selke GW; Garattini L; Kwon HY; Gulbinovic J; Lipinska A; Pomorski M; McClure L; Furst J; Gambogi R; Ortiz CH; Santos VCC; Araujo DV; Araujo VE; de Assis Acurcio F; Alvares-Teodoro J and Guerra-Junior AA. Integrative review of managed entry agreements: Chances and limitations. PharmacoEconomics 2020; 38: 1165-1185
  • Esandi ME; Gutierrez-Ibarluzea I; Ibargoyen-Roteta N and Godman B. An evidence-based framework for identifying technologies of no or low-added value (nlvt). International Journal of Technology Assessment in Health Care 2020; 36: 50-57
  • Matlala M; Gous AGS; Meyer JC and Godman B. Formulary management activities and practices implications among public sector hospital pharmaceutical and therapeutics committees in a South African province. Frontiers in Pharmacology 2020; 11 (1267): 1-13
  • Chigome AK; Matlala M; Godman B and Meyer JC. Availability and use of therapeutic interchange policies in managing antimicrobial shortage among South African public sector hospitals, findings and implications. Antibiotics-Basel 2020; 9(4): 1-11
  • Mwita JC; Godman B and Esterhuizen TM. Statin prescription among patients with type 2 diabetes in Botswana: findings and implications. BMC Endocrine Disorders 2020; 20(36)1-9
  • Naiz Q; Godman B; Camplell Stephen and Kibuule D. Compliance to prescribing among public health care facilities in Namibia; findings and implications. International Journal of Clinical Pharmacy 2020; 42: 1227-1236
  • Nusrat T; Akter N; Rahman NAA; Godman B; Rozario DTD and Haque M. Antibiotic resistance and sensitivity pattern of metallo-B-lactamase producing gram-negative bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. Hospital practice (1995) 2020; 48(3): 128-136
  • Pontes C; Zara C; Torrent-Farnell J; Obach M; Nadal C; Vella-Bonann0 P; Ermisch M; Simoens S; Hauegen RC; Gulbinovic J; Timoney A; Martin PA; Mueller T; Nachtnebel A; Campbell S; Selke G; Bochenek T; Rothe CC; Mardare I; Bennie M; Furst J; Malmstrom RE and Godman B. Time to review authorisation and funding for new cancer medicines in Europe? Inferences from the case of olaratumab. Applied Health Economics and Health Policy 2020; 18: 5-16
  • Gad M; Salem A; Qortwijin W; Hill R and Godman B. Mapping of current obstracles for rationalizing use of medicines (corum) in Europe: Current situation and potential solutions. Frontiers in Pharmacology 2020; 11(144): 1-16
  • Haines HM; Meyer JC; Summers RS and Godman B. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in South African district. European Journal of Clinical Pharmacology 2020; (2020): 1-11
  • Haque M; Islam S; Iqbal S; Urmi UL; Kamal ZM; Rahman A; Kama M; Haque M; Jahan I; Islam Z; Hossain MM; Murshid ME; Sefah I; Kurdi A and Godman B. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications. Bangladesh Journal of Medical Science 2020; 19: 36-50
  • Ogunleye OO; Basu D; Mueller D, et al; (Godman B). Response to the novel corona virus (covi-19) pendemic across Africa: successes, challenges and implications for the future. Frontiers in Pharmacology 2020; 11(1205): 1-36
  • Miljkovic N; van Overbeeke E; Godman B; Kovacevic M; Anastasi A; Bochenek T; Huys I and Miljkovic B. Practical implications from European hospital pharmacists on prospective risk assessment for medicine shortages. Frontiers in Pharmacology 2020; 7(407): 1-12
  • Miljkovic N; Godman B; Kovacevic M, et al. Prospective risk assessment of medicines shortages in Europe and Israel: findings and implications. Frontiers in Pharmacology 2020; 11(357): 1-14
  • Makamu P; Bezuidenhout and Matlala M. Prevalence of kidney injury in patients taking tenofovir antiretroviral therapy at a primary health care clinic, in east rand, Gauteng province. Hosptial Practice 2020; (2020): 1-7
  • Alrasheedy AA; Alsaloum MA; Almuzaini AMA; Aba Alkhayi BS; Albishiri AS; Alharbi FF; Alharbi SR; Alodhayb AK; Alfadl AA; Godman B; Hill R and Anaam MS. The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Soudi Arabia. Expert Review of Anticancer Therapy 2020; 18(1): 87-97
  • Godman B; Basu D; Pillay Y; Julius C. Mwita JC; Mutashambara GM; Paramadhas BDA; Tiroyakgosi C; Mbah P; Niba LL; Nonvignon J; Sefah I; Oluka M; Anastasia N. Guantai AN; Kibuule D; Kalemeera F; Mubita M; Fadare J; Ogunleye OO; Distiller LA; Rampamba; Jeffrey Wing J; Mueller D; Alfadl A; Amu AA; Matsebula Z; KalungiaA; Zaranyika T; Masuka N; Wale J; Hill R; Kurdi A; Timoney A; Campbell S and Meyer JC. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Frontiers in Pharmacology 2020; 11(108): 1-20
  • Schellack N; Schellack G; Meyer JC; Malan L; Labuschgne Q; Nxumalo N and Kupa K. Gastro-oesophageal reflux disease: a pharmacist’s perspective for 2020. SA Pharmaceutical Journal 2019; 87(3): 31-37
  •  
  • Mahlaba KJ; Nkwinika VV; Lebelo RL; Meyer JC and Burnet RJ. Cervical cancer screening and prevention. SA Pharmaceutical Journal 2020; 87(4): 16-21
  • Meyer JC; Sibanda M and Burnett RJ. Vaccination against influenza saves lives. SA Pharmaceutical Journal 2020; 87(2): 26-30
  • Sibanda M; Meyer JC; Mahlaba KJ and Burnett RJ. Vaccines for the elderly. SA Pharmaceutical Journal 2020; 87(3): 47-52
  • Schellack N and Naicker P. Hypertension: a review of antihypertensive medication. SA Pharmaceutical Journal 2020; 87(5):20-27
  • Godman B; Basu D; Pillay Y; Almeida PHRF; Mwita JC; Rwegerera GM; Paramadhas BDA; Tiroyakgosi C; Patrick O; Niba LL; Sefah I; Oluka M; Guantai AN; Kibuule D; Kalemeera F; Mubita M; Fadare J; Ogunleye OO; Rampamba EM; Wing J; Mueller D; Alfadl A; Amu AA; Matsebula Z; Kalungia AC; Zaranyika T; Masuka N; Wale J; Hill R; Kurdi A; Timoney A; Campbell S and Meyer JC. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hospital practice (1995) 2020; 48 (2): 51-67
  • Godman B; Haquee M; McKimmf J; Bakarg MA; Sneddonh J, Walei J; Campbellj S; Martinc AP; Hoxhal I; Abilovam V; Bene D. Anand Paramadhasn BDA; Mpinda-Josepho P; Matomep M, Pires de Lemo LL; Sefahs I; Amanj Kurdi A; Opanga S; Jakupi A; Saleem Z, Mohamed Azmi Hassali MA; Kibuule D; Fadarey J; Bochenekz T; Rothez C; Furst J; Markovic-Pekovic V; Bojani L; Schellack N; Meyer JC; Matsebula Z; Phuong TNT; Binh Nguyen Thanh BN; Saira Jan S; Aubrey Kalungia A; Mtapuri-Zinyowera S; Sartelli M and Hill R. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for he future. Current Medical Research and Opinion 2020; 36 (2): 301-327
  • Kurdi A; Abutheraa N; Akil L and Godman B. A systematic review and meta-analysis of the use of reninangiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far? Pharmacology Research & Perspectives 2020; e00666: 1-24
  • Kibuule D; Aiases P; Ruswa N; Timothy William Rennie TW; Verbeeck RK, Godman B and Mubita M. Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia. European Respiratory Journal 2020; 6: 1-12
  • Khan TA; Hussain S; A Ikram A; Mahmood S; Riaz H; Ayesha Jamil A; YG; Amin A; Haider YG; Sandhu M; Mushtaq A; Barbui C; Johnson CF and Godman B. Prevalence and treatment of neurological and psychiatric disorders among tertiary hospitals in Pakistan; findings and implications. Hospital practice 2020; 48 (3): 145-160
  • Kim Y; Kwon Y-H; Godman B; Evelien Moorkens E; Simoens S; and Bae S. Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? Frontiers in Pharmacology 2020; 11 (970: 1-12
  • Godman B; McCabe H; Leong TD; Mueller D; Martin A; Hoxha I; Mwita JC; Rwegerera GM; Massele  A; de Oliveira Costa J; Macedo do Nascimento RCR; Pires de Lemos LL; Tachkov K; Milushewa  P; Patrick O; Niba LL; Laius O; Sefah I; Abdulsalim S; Soleymani F; Guantai AN; Achieng L; Oluka M; Jakupi A; Logviss K; Hassali MA; Kibuule D; Kalemeera F; Mubita M; Fadare J; Ogunleye OO; Saleem Z; Hussain S; Bochenek T; Mardare I; Alrasheedy AA; Furst J; Tomek D; Markovic-Pekovic D; Rampamba EM; Alfadl A; Amu AA; Matsebula Z; Thi Phuong N; Thanh BN; Kalungia AC; Zaranyika T; Masuka N; Olaru IO; Wale J; Hill R; Kurdi A; Timoney A; Campbell S and  Meyer JC. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. Expert Review of Pharmacoeconomics and Outcomes Research 2020; 20 (1): 1-26
  • Modisakeng C; Matlala M; Godman B and Meyer JC. Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Services Research 2020; 20 (234): 1-10
  • Fynna A; Helberg E; Godman B and Meyer JC. Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications. Hospital practice 2020; 48 (2): 92-99
  • Salas M; Lopes LC; Godman B; Truter I; Hartzema AG; Wettermark B; Fadare J; Burger JR; Appenteng K; Donneyong M; Arias A; Ankrah D; Ogunleye OO; Lubbe M; Horne L; Bernet J; Gómez-Galicia DL; del Carmen Garcia Estrada M; Oluka MN; Massele A; Alesso L; Comoglio RH; da Costa Lima E; Vilaseca C and Bergman UIF.  Challenges facing drug utilization research in the Latin American region. Pharmacoepidemiology and Drug Safety 2020; 29: 1353-1363
  • Olaru ID; Meierkord A; Godman B; Ngwenya C; Fitzgerald F; Dondo V; Ferrand RA and Kranzer K. Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe. Journal of Chemotherapy 2020; 32 (8): 456-459
  • Godman B; Haque M; Islam S; Iqbal S; Urmi UL; Kamal ZM; Shuvo SA; Rahman A; Kamal M; Haque M; Jahan I; Islam Z; Hossain MM; Munzur-E-Murshid; Kumar S; Jaykaran Charan J; Bhatt R; Dutta S; Jha Abhayanand P; Sharma Y; Saleem Z; Thi Phuong TN; Kwon H-Y; Kurdi A; Wale J and Sefah I. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. Frontiers in Public Health 2020; 8: 1-19
  • Macedo do Nascimento RCR; Mueller T; Godman B; Stewart SM; Hurding S; Francisco de Assis Acurcio F; Guerra Junior AF; Teodoro JA; Morton A; Bennie M and Kurdi A. Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.  British Journal of Clinical Pharmacology 2020; 86: 2349-2361
  • Afriyie DK; Asare GA; Amponsah SK and Godman B. COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana. Journal of Infection in Developing Countries 2020; 14 (8): 838-843
  • Kalemeera F; Godman B; Stergachis A and Rennie T. Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications. Hospital practice 2020; 48 (1): 35-40
  • Garcia MM; Azevedo PS; Mirelman A; Safatle LP; Lunes R; Bennie MC; Godman B and Guerra Junior AA. Funding and Service Organization to Achieve Universal Health Coverage for Medicines: An Economic Evaluation of the Best Investment and Service Organization for the Brazilian Scenario. Frontiers in Pharmacology 2020; 11: 1-152
  • Mbongwe B; Moinami J; Masupe T; Tapera R; Molefe T; Erick P; Godman B and Massele A. Nature and sources of poisoning in patients admitted to a referral hospital in Gaborone, Botswana; findings and implications. Hospital practice 2020; 48 (2): 100-107
  • Kurgat EK; Weru I; Wata D; Godman B; Kurdi A and Guantai AN. Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications. Journal of Oncology Pharmacy Practice 2020; 26 (3): 666-679
  • Nyamua DG; Guantaib AN; Osanjob GO; Godman B and Aklillu E. Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya. Expert Review of Cardiovascular Therapy 2020; 18 (3): 165-1732
  • Miljkovic´N; Godman B; van Overbeeke E; Kovacevic´ M; Tsiakitzis K; Apatsidou A; Nikopoulou A; Yubero CG; Horcajada LP; Stemer G; Kuruc-Poje D; De Rijdt T; Bochenek T; Huys I and Miljkovic B. Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. Frontiers in Medicine 2020; 7 (157): 1-14